We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PCI improved angina symptoms at 12 weeks vs. a sham ...

Older patients enrolled in the ISCHEMIA trial saw their angina symptoms improve with an invasive strategy as compared with more-conservative management, but unlike younger patients in the trial, they ...

A heart attack is a medical emergency that requires an immediate call to the emergency services. However, there are sometimes warning signs that can show up weeks in advance that should prompt you to ...

PARIS — After the first major prospective study to associate percutaneous intervention (PCI) with symptom relief in stable angina captured international attention, a new analysis of the ...

ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...

Please provide your email address to receive an email when new articles are posted on . Gene therapy may be an effective treatment for “no-option” refractory angina. XC001 improved exercise capacity ...

Complete revascularization with PCI results in better health status for patients with multivessel, stable CAD than either incomplete revascularization or a conservative strategy of guideline-directed ...

Heart disease in women rarely arrives with drama. More often, it whispers — through fatigue, breathlessness, disturbed sleep or an unexplained heaviness that’s easy to dismiss. Yet behind these subtle ...

ATLANTA, GA — Despite failing to increase perfusion as hypothesized, a coronary sinus reducer (CSR) in a sham-controlled randomized trial meaningfully reduced angina and improved quality of life in ...